drug contamination
![Contamination Worries Prompt Scynexis to Recall Brexafemme, Putting Trials on Hold Following GSKās Manufacturing Review](https://pharmtales.com/wp-content/uploads/2023/09/Contamination-Worries-Prompt-Scynexis-to-Recall-Brexafemme-Putting-Trials-on-Hold-Following-GSKs-Manufacturing-Review.jpg)
Contamination Worries Prompt Scynexis to Recall Brexafemme, Putting Trials on Hold Following GSKās Manufacturing Review
Anika Sharma
In a surprising development, Scynexis is taking a precautionary step to withdraw its antifungal medication, ibrexafungerp, marketed as Brexafemme, from ...